Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA's Overreach on Compounded Peptides Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn